Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 2 institutions in 1 country.
Erine Craey4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-6052-6325
Fabian HulpiaLaboratory of Medicinal Chemistry, Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-7470-3484
Jeroen Spanoghe4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-4427-0948
Simona Manzella4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.
Lars E Larsen4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.
Mathieu Sprengers4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.
Dimitri De BundelResearch Group Experimental Pharmacology, Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Center for Neurosciences, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
Ilse SmoldersResearch Group Experimental Pharmacology, Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Center for Neurosciences, Vrije Universiteit Brussel, 1090 Brussels, Belgium.ORCID 0000-0003-2140-0751
Evelien Carrette4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.
Jean Delbeke4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0001-9542-3599
Kristl Vonck4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-2671-2650
Paul Boon4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.
Serge Van CalenberghLaboratory of Medicinal Chemistry, Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-4201-1264
Wytse J Wadman4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.
Robrecht Raedt4Brain, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-8939-0169
Ghent University · BEVrije Universiteit Brussel · BE
Funding
Research Foundation Flanders-FWO 1S65521N
6 · The paper itself
Abstract
We report the design, synthesis, and validation of the novel compound photocaged N
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Ex Vivo Feedback Control of Neurotransmission Using a Photocaged Adenosine A1 Receptor Agonist. · full record | OpenQuestion